Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
autosomal recessive spinocerebellar ataxia 10
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
12/11/2024
Evidence/Notes:

ANO10 was first reported in relation to autosomal recessive cerebellar ataxia in 2010 (Vermeer et al., PMID: 21092923). The ANO10 gene is a member of the anoctamin family and encodes a transmembrane protein that has various functions including phospholipid scrambling, chloride channel activity, and calcium signaling (PMID: 35648332). Autosomal recessive cerebellar ataxia due to variants in ANO10 is characterized by gait and limb ataxia, dysarthria, nystagmus, and cerebellar atrophy on brain imaging (PMID: 21092923). Other features may be present as well and age of onset is variable (PMID: 36698452).

Six variants (2 nonsense, 2 frameshift, 1 missense, 1 canonical splice-site) that have been reported in 5 probands in 3 publications (PMIDs: 21092923, 23551081, 25133958) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of pathogenicity is unknown.

This gene-disease relationship is also supported by experimental evidence including alteration of calcium signaling in mouse intestinal epithelial cells (PMID: 27838374), alteration of endosomal retrograde transport in mouse embryonic fibroblasts (PMID: 32620747), and a knockout mouse model displaying impairment of neuromuscular function (PMID: 32620747).

In summary, there is definitive evidence supporting the relationship between ANO10 and autosomal recessive cerebellar ataxia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date December 11, 2024 (SOP Version 10).

PubMed IDs:
21092923 23551081 25133958 27838374 32620747
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.